Selected article for: "cohort study and information study report"
Author: Dai, Mengyuan; Liu, Dianbo; Liu, Miao; Zhou, Fuxiang; Li, Guiling; Chen, Zhen; Zhang, Zhian; You, Hua; Wu, Meng; Zheng, Qichao; Xiong, Yong; Xiong, Huihua; Wang, Chun; Chen, Changchun; Xiong, Fei; Zhang, Yan; Peng, Yaqin; Ge, Siping; Zhen, Bo; Yu, Tingting; Wang, Ling; Wang, Hua; Liu, Yu; Chen, Yeshan; Mei, Junhua; Gao, Xiaojia; Li, Zhuyan; Gan, Lijuan; He, Can; Li, Zhen; Shi, Yuying; Qi, Yuwen; Yang, Jing; Tenen, Daniel G.; Chai, Li; Mucci, Lorelei A.; Santillana, Mauricio; Cai, Hongbing
Title: Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak
  • Cord-id: scw4p9wq
  • Document date: 2020_4_28
    • ID: scw4p9wq
    Snippet: The novel COVID-19 outbreak has affected more than 200 countries and territories as of March 2020. Given that patients with cancer are generally more vulnerable to infections, systematic analysis of diverse cohorts of patients with cancer affected by COVID-19 is needed. We performed a multicenter study including 105 patients with cancer and 536 age-matched noncancer patients confirmed with COVID-19. Our results showed COVID-19 patients with cancer had higher risks in all severe outcomes. Patient
    Document: The novel COVID-19 outbreak has affected more than 200 countries and territories as of March 2020. Given that patients with cancer are generally more vulnerable to infections, systematic analysis of diverse cohorts of patients with cancer affected by COVID-19 is needed. We performed a multicenter study including 105 patients with cancer and 536 age-matched noncancer patients confirmed with COVID-19. Our results showed COVID-19 patients with cancer had higher risks in all severe outcomes. Patients with hematologic cancer, lung cancer, or with metastatic cancer (stage IV) had the highest frequency of severe events. Patients with nonmetastatic cancer experienced similar frequencies of severe conditions to those observed in patients without cancer. Patients who received surgery had higher risks of having severe events, whereas patients who underwent only radiotherapy did not demonstrate significant differences in severe events when compared with patients without cancer. These findings indicate that patients with cancer appear more vulnerable to SARS-CoV-2 outbreak. SIGNIFICANCE: Because this is the first large cohort study on this topic, our report will provide much-needed information that will benefit patients with cancer globally. As such, we believe it is extremely important that our study be disseminated widely to alert clinicians and patients. This article is highlighted in the In This Issue feature, p. 747

    Search related documents:
    Co phrase search for related documents
    • achieve necessary and lung cancer: 1
    • active therapeutic and acute ards respiratory distress syndrome: 1, 2, 3
    • active therapeutic and acute kidney injury: 1
    • active therapeutic and logistic regression: 1
    • active therapeutic and lung cancer: 1, 2
    • active treatment and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • active treatment and acute kidney injury: 1, 2, 3
    • active treatment and additional risk factor: 1
    • active treatment and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31
    • active treatment and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • active treatment and lung cancer patient: 1
    • active treatment and lung epithelial cell: 1
    • active treatment and lung function: 1
    • active treatment and lymphoma myeloma: 1, 2
    • acute ards respiratory distress syndrome and admission copd: 1, 2
    • acute ards respiratory distress syndrome and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • acute ards respiratory distress syndrome and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • acute ards respiratory distress syndrome and lung cancer patient: 1
    • acute ards respiratory distress syndrome and lung epithelial cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11